Nanotechnology applications to HIV vaccines and microbicides
Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) remains one of the most serious threats to global health. Today there are no HIV vaccines which can prevent HIV infection. All of the candidates being studied are in the experimental stage. Preventive vaccine candidates are b...
Main Authors: | Sandhya Boyapalle, Subhra Mohapatra, Shyam Mohapatra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Journal of Global Infectious Diseases |
Subjects: | |
Online Access: | http://www.jgid.org/article.asp?issn=0974-777X;year=2012;volume=4;issue=1;spage=62;epage=68;aulast=Boyapalle |
Similar Items
-
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
by: Ruffin Nicolas, et al.
Published: (2012-07-01) -
Immune defense of the female lower reproductive tract and the use of monoclonal antibody-based topical microbicide films to protect against HIV infection
by: Costanzo, Corey
Published: (2016) -
An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana
by: Abdulai Martha A, et al.
Published: (2012-11-01) -
Microbicides for topical immunoprevention of HIV infection
by: Yu. V. Zhernov, et al.
Published: (2019-05-01) -
Vaginal microbicides: An overview
by: Hany Abdel-Aleem
Published: (2011-03-01)